These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 19053080)

  • 1. A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer.
    Meehan J; Gray M; Martínez-Pérez C; Kay C; Wills JC; Kunkler IH; Dixon JM; Turnbull AK
    J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advancements in Nanoparticle-Based Optical Biosensors for Circulating Cancer Biomarkers.
    Amri C; Shukla AK; Lee JH
    Materials (Basel); 2021 Mar; 14(6):. PubMed ID: 33802028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.
    Sayers KT; Brooks AD; Sayers TJ; Chertov O
    PLoS One; 2014; 9(8):e104223. PubMed ID: 25110884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.
    Catteau X; Simon P; Noël JC
    BMC Cancer; 2014 Jul; 14():499. PubMed ID: 25011545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the peptidome of urine from ovarian cancer patients and healthy controls.
    Smith CR; Batruch I; Bauça JM; Kosanam H; Ridley J; Bernardini MQ; Leung F; Diamandis EP; Kulasingam V
    Clin Proteomics; 2014; 11(1):23. PubMed ID: 24982608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.
    Catteau X; Simon P; Vanhaeverbeek M; Noël JC
    PLoS One; 2013; 8(3):e57773. PubMed ID: 23469238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matrices.
    Finoulst I; Pinkse M; Van Dongen W; Verhaert P
    J Biomed Biotechnol; 2011; 2011():245291. PubMed ID: 22203783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response.
    He J; Whelan SA; Lu M; Shen D; Chung DU; Saxton RE; Faull KF; Whitelegge JP; Chang HR
    Int J Proteomics; 2011; 2011():896476. PubMed ID: 22110952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.
    Karagiannis GS; Pavlou MP; Diamandis EP
    Mol Oncol; 2010 Dec; 4(6):496-510. PubMed ID: 20934395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis.
    Balasubramani M; Nakao C; Uechi GT; Cardamone J; Kamath K; Leslie KL; Balachandran R; Wilson L; Day BW; Jordan MA
    Mutat Res; 2011 Jun; 722(2):154-64. PubMed ID: 20816848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland.
    Maller O; Martinson H; Schedin P
    J Mammary Gland Biol Neoplasia; 2010 Sep; 15(3):301-18. PubMed ID: 20811805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
    Gromov P; Gromova I; Bunkenborg J; Cabezon T; Moreira JM; Timmermans-Wielenga V; Roepstorff P; Rank F; Celis JE
    Mol Oncol; 2010 Feb; 4(1):65-89. PubMed ID: 20005186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of serine protease inhibitor-E2 and plasminogen activator expression and secretion by follicle stimulating hormone and growth factors in non-luteinizing bovine granulosa cells in vitro.
    Cao M; Nicola E; Portela VM; Price CA
    Matrix Biol; 2006 Aug; 25(6):342-54. PubMed ID: 16806868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma.
    Liang X; Zhao J; Hajivandi M; Wu R; Tao J; Amshey JW; Pope RM
    J Proteome Res; 2006 Oct; 5(10):2632-41. PubMed ID: 17022634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
    Perera CN; Spalding HS; Mohammed SI; Camarillo IG
    Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers.
    Dowling P; Clynes M
    Proteomics; 2011 Feb; 11(4):794-804. PubMed ID: 21229588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1 in differentiated thyroid cancer: Dr. Jekyll and Mr. Hyde.
    Ghoneim C; Soula-Rothhut M; Rothhut B
    Connect Tissue Res; 2008; 49(3):257-60. PubMed ID: 18661355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines.
    Liang X; Huuskonen J; Hajivandi M; Manzanedo R; Predki P; Amshey JR; Pope RM
    Proteomics; 2009 Jan; 9(1):182-93. PubMed ID: 19053080
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.